Atorvastatin PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified pharmaceutical company offering a Atorvastatin PCD pharma franchise across India. Our portfolio spans 25 Atorvastatin formulations in Capsule and Tablet forms, backed by consistent quality and monopoly-based distribution rights for our franchise partners.

What is Atorvastatin?

Atorvastatin is a statin (HMG-CoA reductase inhibitor) that blocks the liver's key cholesterol-producing enzyme, lowering LDL ("bad") cholesterol and triglycerides while modestly raising HDL. This reduces the build-up of arterial plaque and the risk of cardiovascular events. Its profile is documented on PubChem.

Therapeutic Applications

Atorvastatin tablets are prescribed for hypercholesterolaemia and mixed dyslipidaemia, and for the primary and secondary prevention of cardiovascular disease, often in fixed-dose combinations with aspirin, clopidogrel, fenofibrate or ezetimibe. It is prescribed by cardiologists, physicians, diabetologists and endocrinologists.

Why Atorvastatin is a High-Potential Molecule for Distributors

Statins are among the most prescribed drug classes worldwide, and atorvastatin leads the segment on the back of India's rising burden of diabetes and heart disease. Lifelong daily dosing produces reliable, compounding repeat demand, while combination products with aspirin or fenofibrate open premium price points. With 25 formulations, a distributor can match every prescriber preference and build a comprehensive lipid-management line within a cardio-diabetic portfolio.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers district and state-wise monopoly rights, WHO-GMP certified and DCGI-approved manufacturing, attractive promotional inputs, and the backing of a network of 1000+ franchise partners. Our transparent supply and billing model helps you build a profitable, protected business in your territory.

References

1. PubChem — Atorvastatin
2. MedlinePlus — Cholesterol Medicines
3. PubMed — Atorvastatin literature